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Purpose: Penetrating keratoplasty has a very poor outcome compared with adults if performed in the first years of life.
Rejection in these young patients occurs even in the absence of known immunological risk factors. Recently, a baby rat
model was introduced and an essential contribution of natural killer (NK) cells during allograft rejection was suggested.
To analyze this, NK cells were depleted in baby rats before keratoplasty.
Methods: Allogeneic keratoplasty was performed between Lewis and Fisher rats. The recipient's ages were 10 and 3
weeks, respectively. NK cells were depleted by an intraperitoneal injection of a monoclonal antibody. All experiments
were controlled by the injection of isotypic control antibodies and syngeneically. Survival rates were calculated and cellular
infiltrates were analyzed histologically.
Results: NK cell depletion did delay median graft survival times in a statistically significantly way compared with the
control animals (p<0.01). At median rejection time points, macrophages, CD4+ T cells and CD25+ leukocytes infiltrated
to a greater extent in the depleted recipients. No significant changes in the cell numbers of infiltrating CD8+ T cells were
observed.
Conclusions: We conclude that NK cells play a role during allograft rejection in baby rats, but their effect is replaceable.
A greater infiltration of macrophages and CD4+ T cells suggests that they might compensate for the missing NK cells’
response in this experimental setting. Our results represent another step toward understanding the complex mechanisms
of an accelerated corneal graft rejection in infant recipients.
Corneal transplantation has a very good outcome in terms
of graft survival. In humans in low-risk situations, allograft
survival rates are more than 90%. The survival rate decreases
dramatically if other issues exist [1], such as ocular surface
inflammation  (e.g.,  infection,  chemical  burn,  re-
transplantation) or immune-mediated disease (e.g., allergies,
rheumatologic disorders). In these high-risk patients, corneal
allograft survival is reduced to 30%. A third group of patients
includes young children (<3 years of age) where graft survival
occurs in only 15%–35%, despite the absence of local or
systemic inflammation [2-4]. Taking into consideration that
the risk of rejection in solid organ transplantation in children
(e.g., kidney) is not increased [5,6], this clinical observation
following keratoplasty is surprising. The importance of a high
success rate following infant keratoplasty is emphasized by
the  fact  that  any  form  of  uncorrected  corneal  opacity  in
infancy leads to amblyopia. To develop effective treatment
strategies  that  promote  graft  survival  following  infant
keratoplasty and prevent the development of amblyopia, it is
of  intrinsic  interest  to  understand  the  mechanisms  of  the
rejection process in an infant’s eye.
To study the immune mechanisms of corneal transplant
rejection,  animal  models  are  widely  used.  In  rodent
keratoplasty,  CD4+  T  cells  have  been  shown  to  be  key
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elements during immunological graft failure [7]. Also other
immune factors as CD8+ T cells, macrophages or natural killer
(NK) cells have been shown to contribute to some extent to
graft failure [8-11]. Hori et al. [12] showed for the first time
that  the  corneal  epithelium  plays  a  major  role  and
hypothesized that it acts during the process of sensitizing the
immune  system  toward  a  response.  The  contribution  of
epithelium-born  antigens  during  the  priming  process  was
additionally proven by Saban et al. [13]. A substantial amount
of corneal corneal antigen presenting cells (APC) is located
within the epithelial layer, which might explain these findings.
In the context of high-risk keratoplasty, preformed corneal
vessels and an elevated number of corneal APC are linked to
promoting  a  faster  presentation  of  antigen  and  a  faster
stimulation of the alloresponse against a corneal graft [14,
15].
Taken together, an allograft rejection is a multi-factorial
scenario  mediated  by  systemic  and  local  immune  factors.
Moreover, its different components can compensate for each
other to a certain extent. Even if a corneal allograft faces this
complex system, the majority of transplants are accepted in
adult humans. In short, the survival of a transplanted cornea
can be traced back to the immune status of the eye [9,10]. This
exceptional position in the immune system is, to a certain
extent,  not  applicable  in  high-risk  keratoplasty.  However,
little is understood about mechanisms of the ocular immune
privilege  in  young  individuals.  The  clinically  increased
rejection rate of a corneal allograft in young children suggests
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1928differences in the protective ocular immune situation: In this
context  changes  in  juvenile  immune  privilege,  e.g.,
functionally  different  ocular  APC  or  alterations  in  the
components of the aqueous humor might play a role.
To analyze changes of the ocular immune privilege or
related immune mechanisms in infants and their impact during
infant keratoplasty, we recently introduced a baby rat model
for  corneal  transplantation  that  resembles  the  situation  in
young  humans:  Without  additional  immunological
differences  or  risk  factors,  young  recipients  of  a  corneal
allograft show a significantly earlier rejection compared with
old rats [16]. We confirmed a dominating infiltration of NK
cells at all stages of the rejection period that even outlasted
the actual rejection time point for grafts in young recipient
animals compared with old rats [16,17]. During infancy, NK
cells  are  a  part  of  the  innate  immune  system  and  can
compensate,  to  a  certain  extent,  for  the  missing  T  cell
repertoire [18-20]. Our hypothesis that NK cells contribute to
the  process  of  immunological  graft  failure  following
keratoplasty in young recipient rats is therefore likely and was
analyzed by depletion experiments with the baby rat model.
METHODS
Animals and anesthesia: Inbred female Fisher (Rt1lv1) and
Lewis (Rt1l) rats (Charles River, Sulzfeld, Germany) were
used as donors and recipients. All animals were treated in
accordance to the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research. The rats were anesthetized
with  a  short  inhalation  of  isofluran  followed  by  an
intraperitoneal  injection  of  a  mixture  of  ketamin  (Essex,
München, Germany), xylacin (Bayer, Leverkusen, Germany)
and atropin (Braun, Melsungen, Germany).
Corneal  transplantation:  Orthotopic  penetrating
keratoplasties  were  performed  as  described  [16].  Briefly,
donor buttons from the central cornea were obtained using a
2.5  mm  trephine  and  subsequently  stored  in  conservation
medium (Medium2; Biochrom, Berlin, Germany). The central
cornea of a recipient was removed using a 2.0 mm trephine.
The  graft  was  fixed  with  eight  interrupted  sutures  (11.0
Ethilon;  Ethicon,  Norderstedt,  Germany).  Finally,  a
blepharoraphy was applied for three days.
Clinical graft assessment and rejection kinetics: All grafts
were examined daily by two independent investigators for
signs of opacity according to an international score [16,21].
Grafts  with  technical  complications  such  as  cataracts,
infections, loss of the anterior chamber or massive hyphema
were excluded. The time point of rejection was identified as
soon as an opacity score of 4 (complete opacity) was recorded.
NK cell depletion: Three days and then one day before the
keratoplasty a monoclonal antibody (clone 3.2.3 – mouse-
anti-rat  CD161,  provided  by  Bernhard  Vanhove,  Inserm,
Nantes, France) was injected intraperitoneally to systemically
deplete NK cells [22]. Control animals received an isotypic
antibody. Injections were repeated every five days following
the transplantation. NK cell depletion was controlled by flow
cytometric analysis of blood, spleen and lymph nodes. The
samples  were  stained  with  anti-CD3  FITC  (clone  G4.18;
eBioscience - NatuTec, Frankfurt, Germany) and anti-CD161
Pe  (clone  10/78;  AbD  Serotec,  Düsseldorf,  Germany)
antibodies.
Groups: Only 10-week-old (old) donor buttons were used,
considering the fact that in humans the majority of grafts are
derived  from  adults.  Four  different  donor  recipient
combinations were analyzed. Group NK+ consisted of Fisher
donors’ corneal buttons grafted to 3-week-old (young) Lewis
recipients that were treated with an isotypic control antibody.
In  group  NK-,  young  Lewis  recipients  were  systemically
depleted of their NK cells and subsequently grafted with a
Fisher  cornea.  The  corresponding  syngeneic  controls  are
indicated as syn.NK+ and syn.NK-, respectively. All groups
are shown in Table 1. Additionally, old recipient Lewis rats
were NK cell depleted or injected with the isotypic control
antibody  before  keratoplasty.  Each  group  consisted  of  12
recipients.
Immunohistochemistry: The bulbi of six rats per group were
snap  frozen  and  cryosections  were  taken  for
immunohistological analysis [16]. Specimens were fixed with
acetone. Unspecific binding was blocked by incubation in a
Tris buffer containing 10% calf serum. Primary mouse and
TABLE 1. SYSTEMATIC OVERVIEW OF TRANSPLANTATION GROUPS.
Group Donor Recipient Treatment
NK+ Fisher lewis Isotype
NK- Fisher Lewis 3.2.3
Syn. NK+ Lewis Lewis Isotype
Syn. NK- Lewis Lewis 3.2.3
        All transplantation groups are shown systematically: If the isotypic control antibody was injected groups are named NK+. Groups
        where NK cells were depleted by injecting 3.2.3 (NK cell depleting antibody) are named NK-. If not mentioned an allogeneic
        transplantation was performed (i.e. Fisher donor and Lewis recipient); syngeneic transplantation (i.e. Lewis donor and recipient,
        respectively) is highlighted by adding "syn." the group name.
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1929anti-rat antibodies were applied to the sections. A biotinylated
rabbit anti-mouse secondary antibody was used to bind a
streptavidine alcaline phosphatase. After incubation with the
substrate (alkaline phosphatase kit 1; Vector, Burlingame,
VT), sections were counterstained with Mayer’s hematoxylin.
Positively stained cells were counted within three squares in
the grafted corneal stroma by two independent investigators
and calculated as mean cellular infiltrate per mm2.
Antibodies for histological analysis: Primary antibodies used
for  immunohistochemistry  were  anti-CD4  (clone  W3/25),
anti-CD8  (clone  OX-8),  anti-CD161  (clone  10/78),  anti-
CD163 (clone ED2), anti-dendritic cells (clone OX-62) and
anti-CD25  (clone  Ox-39).  All  of  these  antibodies  were
purchased  from  AbD  Serotec.  The  secondary  biotinylated
polyclonal  rabbit  and  anti-mouse  immunoglobulin  and
streptavidine alkaline phosphatase were obtained from Dako
(Hamburg, Germany).
Statistics: The time interval from corneal transplantation to
the onset of rejection was analyzed using the Kaplan–Meier
method and the groups were compared using the log-rank test.
The densities of the infiltrating immune cells were compared
statistically using the t-test.
RESULTS
Delayed  corneal  allograft  rejection  in  NK-cell-depleted
young recipients: After two intraperitoneal injections of 3.2.3
monoclonal antibody into the Lewis rat, blood samples were
taken to analyze the efficacy of the depletion. The samples
were stained and analyzed by flow cytometry for the presence
of CD3+ and CD161+ cells. The 3.2.3-injection resulted in a
complete absence of CD3-CD161+ NK and of CD3+CD161+
NKT cells. NK cell staining is shown in Figure 1A. Cell
numbers of CD3+CD161- T cells were not affected by the
treatment. Similar results were obtained for the spleens and
lymph nodes. No differences in the efficacy of the treatment
between young and old Lewis rats were observed (not shown).
According to the protocol, young recipients were NK cell
depleted  (NK-)  or  treated  with  control  antibodies  (NK+)
before keraoplasty. None of the syngeneic controls (syn.NK
+  and  syn.NK-)  rejected  a  corneal  allograft.  Allogeneic
control animals (NK+) rejected after a median time of eight
days. Depletion of NK cells led to a statistically significant
delay of the rejection with a median rejection time point at
postoperative  day  11  in  group  NK-  (p<0.01;  Figure  1B).
Moreover, 3.2.3-treatment did not affect the rejection time
course in old recipients (Figure 1C).
Infiltration of CD45+ leukocytes and T cell subpopulations:
At the time points of rejection infiltration of CD45+ leukocytes
was calculated within the allografts of young recipients. As
shown  in  Figure  2A,B,  no  significant  differences  in  the
absolute leukocytic infiltrate were observed between control
Figure  1.  Graft  survival  in  NK  cell
depleted  recipients.  A:  3-week-old
(young) Lewis rats were injected twice
with  a  NK  cell  depleting  antibody
(3.2.3). Blood was taken and analyzed
by flow cytometry for the presence of
CD3+ and CD161+ cells. Intraperitoneal
injection  of  3.2.3  lead  to  complete
absence of CD161+ NK/NKT cells and
did  not  affect  cell  numbers  of
CD3+CD161- T cells. FACS data shown
are  representative  for  control  animals
that received an isotypic antibody (NK
+) or 3.2.3-treated rats (NK-). B: After
injections of either isotyp controls (NK
+) or 3.2.3 (NK-) allogeneic penetrating
keratoplasty  was  performed  and  the
grafts  were  assessed  clinically  until
rejection occurred. Albeit all recipients
of  both  allogeneic  groups  rejected,
animals  of  group  NK-  showed  a
statistically  significantly  delay  of
immunological  allograft  failure
(p<0.01). None of the syngeinic controls
(groups  syn.NK+  and  syn.NK-,
respectively) rejected. C: NK cells were
depleted in 10-week-old (old) Lewis rats
(NK-) or isotypic antibody was injected
(NK+). NK cell depletion had no effect
on graft survival rates.
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1930and NK cell-depleted groups. Because T cells are known to
be key elements during corneal allograft failure, CD25 that is
expressed on activated T cells was analyzed. In addition,
CD4+  and  CD8+  T  cells  were  stained  in  grafts  at  the
aforementioned time points. CD25+ cells were stained to a
statistically significant stronger extent in NK-cell-depleted
animals  compared  with  control  animals  (p<0.01;  Figure
3A,B). Similar results were observed for infiltrating CD4+ T
cells  (p<0.01;  Figure  3C,D),  whereas  no  significant
differences for CD8+ T cells were shown (Figure 3E,F).
Increase  of  infiltrating  macrophages  in  NK-cell-depleted
recipients:  Ox-62+  dendritic  cells  (DC)  and  CD163+
macrophages were stained within corneal allografts at the time
point of allograft rejection in young treated recipients. In
addition, CD161+ cells were also calculated to finally prove
their  systemic  absence  in  NK-cell-depleted  animals.  As
shown in Figure 4A,B, NK cell depletion did not affect the
infiltration of Ox-62+ DC. CD163+ macrophages infiltrated at
a statistically significantly stronger level in the rejected grafts
of  NK-cell-depleted  recipients  compared  with  the  control
animals (Figure 4C,D). No CD161+ NK cells could be stained
in  rejected  grafts  of  NK-cell-depleted  Lewis  recipients,
whereas a substantial amount of CD161+ cells infiltrated in
the control animals (p<0.001; Figure 4E,F).
DISCUSSION
In humans, corneal graft failure in children under three years
of age occurs more frequently than in adults [2-4]. Because
any  form  of  uncorrected  corneal  opacity  leads  to  the
development of life-long amblyopia in these children, it is of
great clinical interest to improve corneal graft survival in
children.  Recently,  we  introduced  the  baby  rat  model  for
keratoplasty  that  allows  us  to  study  the  underlying
mechanisms experimentally. Analogous to humans, young
rats rejected a corneal allograft significantly earlier than did
old animals. Histological analysis demonstrated a stronger
infiltration of NK cells in the young rats compared with the
old recipient rats [16]. We therefore hypothesized that NK
cells  contribute  to  immunological  graft  failure  following
keratoplasty in infants.
To analyze this hypothesis, NK cells were depleted in
young  Lewis  rats  before  keratoplasty  (Figure  1A).  The
systemic absence of NK cells was proven by flow cytometry
of blood and lymphoid organs as well as histologically in
peripheral tissues (Figure 1A and Figure 4). Importantly, no
negative  side  effects  in  the  T  cell  pool  were  observed,
excluding that the key player for corneal graft rejection in old
recipients  (i.e.,  T  cells)  would  also  be  affected.  NK  cell
depletion lead to a significant delay of the median rejection
time point compared with control-treated animals (day 11
versus day 8; Figure 1B). This finding demonstrated that NK
cells did contribute to corneal graft rejection in young rats,
whereas their influence on graft rejection in old recipients
seemed to be negligible (Figure 1C). From mice, it is known
that  a  missing  component  of  their  immune  system  is
replaceable by other factors, such as macrophages, CD8+ T
cells  or  complementary  factors  [7,8].  Depending  on  the
conditions at the time of transplantation (i.e., low risk, high
risk, type of model used, etc.), the composition of the various
immune  factors  is  variable  and  some  components  can
compensate for others [9]. However, the different immune
mediators can reach a critical limit that leads to rejection in
diverse pathways whereby rejection kinetic is affected. A
similar  event  seems  to  happen  in  our  model  and  will  be
discussed later.
To understand compensatory mechanisms at the graft
side that finally cause graft rejection in young rats in more
detail,  we  did  histological  analysis  of  rejected  grafts  and
compared them to the total cellular infiltration. As shown in
Figure 2, the total amount of CD45+ leukocytes did not vary
Figure 2. Analysis of graft-infiltrating leukocytes. At the time points of corneal allograft rejection CD45+ leukocytes were stained and calculated
within the graft. A: Histological staining of graft infiltrating CD45+ leukocytes is shown exemplarily. B: Calculation from 4 representative
grafts revealed no statistically significant differences in the total amount of infiltrating cells in rejected grafts of 3.2.3- and control treated
recipients, respectively (NS=not significant).
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1931between both allogeneic groups. This finding underlines our
hypothesis that the immune system is compensating for a
missing  component.  It  clearly  demonstrates  that  a  critical
amount of cellular infiltration is required and is sufficient to
achieve graft rejection [16]. NK cell depletion delays the time
point when the critical and compensatory immunological cell
infiltration is reached without preventing rejection.
We analyzed specific leukocyte populations within this
immune  infiltration  to  get  more  insight  into  the  actual
compensatory mechanisms that still have the capacity to reject
the corneal graft. NK cell depletion led to an increase of graft
infiltrating CD25+ cells, pointing to a contribution of T cells
in the rejection process of treated rats. Only a slight increase
of CD8+ T cells in NK-cell-depleted recipients was observed,
Figure 3. Analysis of graft-infiltrating T cells. Activated CD25+ T cells and CD4+ and CD8+ T cell subsets were stained at the time points of
corneal allograft rejection and calculated within the graft. A, C, and E show representative histological staining for CD25, CD4, and CD8 in
grafts of treated and control animals, respectively. CD25+ (B) and CD4+ (D) cells infiltrated to a statistically significantly stronger extent in
3.2.3-treated animals when compared to control treated animals (*p<0.01, ** p<0.01). No statistical difference was observed for CD8+ T cells
(NS=not significant; F).
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1932whereas CD4+ T cells infiltrated to a significantly greater
extent (p<0.01; Figure 3). This suggests that CD4+ rather than
CD8+ T cells contribute to the immune reaction to the graft in
NK-cell-deficient  recipients.  However,  it  remains  unclear
whether the infiltrating CD4+ T cells are allo-protective or
allo-reactive as there are CD4+CD25+ T cell subpopulations
with  different  effector  mechanisms:  On  the  one  hand,
regulatory T cells (Treg) with inhibitory functions express
CD4  and  CD25.  A  role  for  these  Treg  was  proposed  in
pediatric liver transplantation [23] and has just recently been
suggested  in  the  mouse  keratoplasty  model  [24].  Their
Figure 4. Analysis of innate immune cells into a corneal graft. Ox-62+ DC and CD163+ macrophages were stained at the time points of corneal
allograft rejection and calculated within the graft. Additionally CD161+ cells were counted within rejected corneal allografts to finally prove
the efficacy of the depletion protocol in the peripheral tissue. Representative histological staining is shown for Ox-62 (A), CD163 (C), and
CD161 (E) in NK deficient and control animals. B: No statistical difference was observed for infiltrating Ox-62+ DC. D: CD163+ macrophages
infiltrated to a statistically significantly stronger extent in 3.2.3-treated animals when compared to control treated animals (*p<0.01). F: No
CD161+ cells were stained in 3.2.3-treated recipients when compared to control treated control animals (**p<0.001).
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1933contribution to a prolonged allograft survival following infant
keratoplasty would therefore also be possible.
On the other hand, effector T cells also express CD4 and
CD25. Their important role during corneal allograft rejection
in adults is indisputable [7] and therefore is also likely in the
baby rat model. It would be necessary to deplete CD4+ T cells
alone or in combination with NK cells to understand their
general contribution to corneal allograft rejection in infants.
To distinguish between activated and regulatory CD4+ T cells,
the expression of the transcription factor forkhead box protein
3 (FoxP3) that is mainly active in Treg [25] could be analyzed
by rtPCR or by flow cytometry within infiltrating CD4+ T
cells. The role of CD4+ lymphocytes populations is likely in
our model; however, their function in the rejection process
remains unclear.
Looking at infiltrating macrophages as another main arm
of the innate immune system that has a stronger influence in
the early times of life [26-28] revealed a significant increase
of  CD163+  macrophages  in  grafts  of  NK-cell-deficient
recipients (p<0.01; Figure 4A,B). Because macrophages have
been  shown  to  affect  immunological  graft  failure  after
keratoplasty in mature mice [29,30], we would suggest that
they could also compensate for NK cell deficiency in infants
and  promote  rejection.  However,  only  depletion  of
macrophages alone by clodronate liposomes [31] or together
with  NK  cell  depletion  would  explain  their  role  during
allograft rejection in young recipients.
Finally and aside from the analysis of the infiltrate of
leukocytes,  it  has  to  be  taken  into  consideration  that  the
depleting antibody used is directed against CD161 expressed
by NK and NKT cells. NKT cells are known to contribute to
the  development  of  anterior  chamber  induced  immune
deviation (ACAID) [32,33], which is one mechanism of the
ocular immune privilege that otherwise promotes the good
survival rates of a corneal allograft [9,10]. In our experimental
setting, both CD161+ cell populations are eliminated (Figure
1A). Therefore, 3.2.3-treatments could have different effects
that  would  explain  the  delayed  rejection:  Initially,  the
aggressive NK cell response to an allograft in young rats
would be weakened and rejection would not occur as fast as
in control animals. At the same time, ACAID-promoting NKT
cells would also be erased. Thereby, one mechanism of the
ocular immune privilege that would otherwise promote graft
survival [31,32] would be weakened as a side effect. This
would explain that rejection would only be delayed but could
still occur in all young recipients (Figure 1B). To exclude that
NK and NKT cells act in this antagonistic way during the
process of corneal graft rejection in young recipients, it would
be  necessary  to  selectively  deplete  every  single  cell
population. Moreover, the effect of the treatment with 3.2.3
on the ability to develop ACAID could be analyzed in this
model.
Considering these data together, we demonstrated that
NK cells contribute to allograft rejection after keratoplasty in
young rats. However they are obviously not solely responsible
because  NK-cell-deficient  young  recipients  still  reject  a
corneal allograft at a rate of 100%. Our results suggest that
the rejection of a corneal allograft in young recipients is a
multi-factorial  process  that  involves  NK  cells  and
macrophages as parts of the innate immunity, as well as T cells
of the developing adaptive immune response. Weakening one
mechanism,  here  by  the  depletion  of  NK  cells,  seems  to
strengthen another one, e.g., macrophages and/or CD4+ T
cells.
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